Oksana A Sergeeva

6PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyReceptors and membrane biologyMolecular targetsData structures and algorithms
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 18, 2025
EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors.

Oksana A Sergeeva, Guixian Jin, Mohosin Sarkar

|Jan 09, 2021
Harnessing the Membrane Translocation Properties of AB Toxins for Therapeutic Applications.

Numa Piot, F Gisou van der Goot, Oksana A Sergeeva

|Mar 19, 2020
Mammalian membrane trafficking as seen through the lens of bacterial toxins.

Francisco Sarmento Mesquita, F Gisou van der Goot, Oksana A Sergeeva

|Aug 27, 2019
Converging physiological roles of the anthrax toxin receptors.

Oksana A Sergeeva, F Gisou van der Goot

|Aug 15, 2019
Co-expression of CCT subunits hints at TRiC assembly.

Oksana A Sergeeva, Cameron Haase-Pettingell, Jonathan A King

|Jan 06, 2019
Anthrax toxin requires ZDHHC5-mediated palmitoylation of its surface-processing host enzymes.

Oksana A Sergeeva, F Gisou van der Goot

Pageof 1